130 related articles for article (PubMed ID: 12017304)
1. Current status and future perspectives of post-operative adjuvant therapy for gastric carcinoma.
Kim R; Yoshida K; Toge T
Anticancer Res; 2002; 22(1A):283-9. PubMed ID: 12017304
[TBL] [Abstract][Full Text] [Related]
2. [Current status and future perspectives on chemotherapy in patients with gastric cancer: can the clinical data from Japan lead to a standard international therapy?].
Kim R; Yoshida K; Toge T
Nihon Geka Gakkai Zasshi; 2001 Oct; 102(10):770-7. PubMed ID: 11681004
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant chemotherapy for gastric cancer in Japan: global and Japanese perspectives.
Sakamoto J; Morita S; Kodera Y; Rahman M; Nakao A
Cancer Chemother Pharmacol; 2004 Sep; 54 Suppl 1():S25-31. PubMed ID: 15309511
[TBL] [Abstract][Full Text] [Related]
4. Clinical relevance of meta-analysis of survival benefit when deciding treatment of adjuvant chemotherapy in gastric cancer.
Kim R; Toge T
Anticancer Res; 2003; 23(2C):1843-6. PubMed ID: 12820467
[TBL] [Abstract][Full Text] [Related]
5. [Meta-analysis of 10 postoperative adjuvant chemotherapies for gastric cancer in CIH].
Nakajima T; Ota K; Ishihara S; Oyama S; Nishi M; Hamashima N
Gan To Kagaku Ryoho; 1994 Aug; 21(11):1800-5. PubMed ID: 8080299
[TBL] [Abstract][Full Text] [Related]
6. Randomized trial of adjuvant chemotherapy with mitomycin, Fluorouracil, and Cytosine arabinoside followed by oral Fluorouracil in serosa-negative gastric cancer: Japan Clinical Oncology Group 9206-1.
Nashimoto A; Nakajima T; Furukawa H; Kitamura M; Kinoshita T; Yamamura Y; Sasako M; Kunii Y; Motohashi H; Yamamoto S;
J Clin Oncol; 2003 Jun; 21(12):2282-7. PubMed ID: 12805327
[TBL] [Abstract][Full Text] [Related]
7. [Complementary treatment to surgery of gastric carcinoma: role of adjuvant and neoadjuvant chemotherapy].
Lise M; Nitti D; Marchet A; Tripodi M; Pilati P; Pasetto L
Chir Ital; 1997; 49(3):35-9. PubMed ID: 9612650
[TBL] [Abstract][Full Text] [Related]
8. [Predictive value of orotate phosphoribosyltransferase in chemoresistant patients with gastric carcinoma who underwent S-1-based neoadjuvant/adjuvant chemotherapy].
Sakurai Y; Kamoshida S; Furuta S; Sunagawa R; Inaba K; Isogaki J; Komori Y; Uyama I; Tsutsumi Y
Gan To Kagaku Ryoho; 2008 Jul; 35(7):1147-55. PubMed ID: 18633253
[TBL] [Abstract][Full Text] [Related]
9. Randomized trial of adjuvant therapy in colon carcinoma: 10-year results of NSABP protocol C-01.
Smith RE; Colangelo L; Wieand HS; Begovic M; Wolmark N
J Natl Cancer Inst; 2004 Aug; 96(15):1128-32. PubMed ID: 15292384
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant therapy for colorectal carcinoma.
Kim R; Yamaguchi Y; Toge T
Anticancer Res; 2002; 22(4):2413-8. PubMed ID: 12174936
[TBL] [Abstract][Full Text] [Related]
11. Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much?
Gill S; Loprinzi CL; Sargent DJ; Thomé SD; Alberts SR; Haller DG; Benedetti J; Francini G; Shepherd LE; Francois Seitz J; Labianca R; Chen W; Cha SS; Heldebrant MP; Goldberg RM
J Clin Oncol; 2004 May; 22(10):1797-806. PubMed ID: 15067028
[TBL] [Abstract][Full Text] [Related]
12. [Current status and problem of adjuvant chemotherapy for curatively resected gastric cancer].
Saka M; Sasako M; Katai H; Sano T
Gan To Kagaku Ryoho; 2000 Nov; 27(13):2033-42. PubMed ID: 11103234
[TBL] [Abstract][Full Text] [Related]
13. An updated meta-analysis of adjuvant chemotherapy after curative resection for gastric cancer.
Liu TS; Wang Y; Chen SY; Sun YH
Eur J Surg Oncol; 2008 Nov; 34(11):1208-16. PubMed ID: 18353606
[TBL] [Abstract][Full Text] [Related]
14. 5-fluorouracil, mitomycin-C, and polysaccharide-K adjuvant chemoimmunotherapy for locally advanced gastric cancer: the prognostic significance of frequent perineural invasion.
Choi JH; Kim YB; Lim HY; Park JS; Kim HC; Cho YK; Han SW; Kim MW; Joo HJ
Hepatogastroenterology; 2007; 54(73):290-7. PubMed ID: 17419278
[TBL] [Abstract][Full Text] [Related]
15. Overview of adjuvant therapy for resected gastric cancer: differences in Japan and the United States.
Ohtsu A; Sasako M
Semin Oncol; 2005 Dec; 32(6 Suppl 9):S101-4. PubMed ID: 16399444
[TBL] [Abstract][Full Text] [Related]
16. Role of surgery in the patients with stage I and II primary gastric lymphoma.
Takahashi I; Maehara Y; Koga T; Sumiyoshi Y; Oshiro T; Baba H; Kohnoe S; Okamura T; Uike N; Matsusaka T; Kume K; Sugimachi K
Hepatogastroenterology; 2003; 50(51):877-82. PubMed ID: 12828109
[TBL] [Abstract][Full Text] [Related]
17. [Efficacy of current adjuvant and neoadjuvant therapeutic concepts in gastric cancer?].
Kretzschmar A; Schlag PM
Zentralbl Chir; 2006 Apr; 131(2):121-5. PubMed ID: 16612778
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant treatment of high-risk, radically resected gastric cancer patients with 5-fluorouracil, leucovorin, cisplatin, and epidoxorubicin in a randomized controlled trial.
Cascinu S; Labianca R; Barone C; Santoro A; Carnaghi C; Cassano A; Beretta GD; Catalano V; Bertetto O; Barni S; Frontini L; Aitini E; Rota S; Torri V; Floriani I; ; Pozzo C; Rimassa L; Mosconi S; Giordani P; Ardizzoia A; Foa P; Rabbi C; Chiara S; Gasparini G; Nardi M; Mansutti M; Arnoldi E; Piazza E; Cortesi E; Pucci F; Silva RR; Sobrero A; Ravaioli A
J Natl Cancer Inst; 2007 Apr; 99(8):601-7. PubMed ID: 17440161
[TBL] [Abstract][Full Text] [Related]
19. Impact of adjuvant chemotherapy in the long-term outcome of patients with resected gastric cancer.
Grau JJ; Martín M; Fuster J; Pera M; García-Valdecasas JC; Bombí JA; Bordas JM; Alcobendas F; Grande L; Estapé J
J Surg Oncol; 2003 Apr; 82(4):234-40. PubMed ID: 12672007
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant chemotherapy in completely resected gastric cancer: a randomized phase III trial conducted by GOIRC.
Di Costanzo F; Gasperoni S; Manzione L; Bisagni G; Labianca R; Bravi S; Cortesi E; Carlini P; Bracci R; Tomao S; Messerini L; Arcangeli A; Torri V; Bilancia D; Floriani I; Tonato M; ; Dinota A; Strafiuso G; Corgna E; Porrozzi S; Boni C; Rondini E; Giunta A; Monzio Compagnoni B; Biagioni F; Cesari M; Fornarini G; Nelli F; Carboni M; Cognetti F; Enzo MR; Piga A; Romiti A; Olivetti A; Masoni L; De Stefanis M; Dalla Mola A; Camera S; Recchia F; De Filippis S; Scipioni L; Zironi S; Luppi G; Italia M; Banducci S; Pisani Leretti A; Massidda B; Ionta MT; Nicolosi A; Canaletti R; Biscottini B; Grigniani F; Di Costanzo F; Rovei R; Croce E; Carroccio R; Gilli G; Cavalli C; Olgiati A; Pandolfi U; Rossetti R; Natalini G; Foa P; Oldani S; Bruno L; Cascinu S; Catalano G; Catalano V; Lungarotti F; Farris A; Sarobba MG; Trignano M; Muscogiuri A; Francavilla F; Figoli F; Leoni M; Papiani G; Orselli G; Antimi M; Bellini V; Cabassi A; Contu A; Pazzola A; Frignano M; Lastraioli E; Saggese M; Bianchini D; Antonuzzo L; Mela M; Camisa R
J Natl Cancer Inst; 2008 Mar; 100(6):388-98. PubMed ID: 18334706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]